![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Second Pharma Co., Ltd. Shangyu City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Levetiracetam, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-219 - Rev 00
This Chemical Type CEP, issued on December 15, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2535 associated with this CEP further emphasizes